Home › Kanser sa Pantog
Pag-aaral pangklinika para sa Kanser sa Pantog na nagre-recruit sa U.S.
142 pag-aaral para sa Kanser sa Pantog ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY34 pag-aaral
- Houston, TX31 pag-aaral
- Nashville, TN31 pag-aaral
- Boston, MA27 pag-aaral
- Dallas, TX27 pag-aaral
- Washington, DC26 pag-aaral
- Los Angeles, CA24 pag-aaral
- Baltimore, MD24 pag-aaral
- St. Louis, MO22 pag-aaral
- Edison, NJ22 pag-aaral
- Seattle, WA21 pag-aaral
- Philadelphia, PA21 pag-aaral
- Chicago, IL21 pag-aaral
- Durham, NC20 pag-aaral
- Cleveland, OH18 pag-aaral
- Columbus, OH18 pag-aaral
- Queens, NY16 pag-aaral
- Atlanta, GA15 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Portland, OR13 pag-aaral
- San Antonio, TX13 pag-aaral
- Austin, TX12 pag-aaral
- Grand Rapids, MI12 pag-aaral
- Orange, CA12 pag-aaral
- San Francisco, CA12 pag-aaral
- Rochester, MN12 pag-aaral
- Kansas City, KS12 pag-aaral
- Denver, CO11 pag-aaral
- San Diego, CA11 pag-aaral
- Staten Island, NY11 pag-aaral
- Detroit, MI11 pag-aaral
- New Rochelle, NY11 pag-aaral
- Irvine, CA11 pag-aaral
- Oklahoma City, OK11 pag-aaral
- Minneapolis, MN11 pag-aaral
- Birmingham, AL11 pag-aaral
- Cincinnati, OH10 pag-aaral
- Salt Lake City, UT10 pag-aaral
- Kansas City, MO10 pag-aaral
- Omaha, NE10 pag-aaral
Ayos sa estado
- Alabama11 pag-aaral
- Alaska3 pag-aaral
- Arizona20 pag-aaral
- Arkansas15 pag-aaral
- California53 pag-aaral
- Colorado20 pag-aaral
- Connecticut10 pag-aaral
- Delaware4 pag-aaral
- District of Columbia17 pag-aaral
- Florida38 pag-aaral
- Georgia18 pag-aaral
- Idaho6 pag-aaral
- Illinois30 pag-aaral
- Indiana14 pag-aaral
- Iowa12 pag-aaral
- Kansas17 pag-aaral
- Kentucky7 pag-aaral
- Louisiana13 pag-aaral
- Maryland36 pag-aaral
- Massachusetts32 pag-aaral
- Michigan25 pag-aaral
- Minnesota24 pag-aaral
- Mississippi3 pag-aaral
- Missouri27 pag-aaral
- Montana7 pag-aaral
- Nebraska11 pag-aaral
- Nevada4 pag-aaral
- New Hampshire3 pag-aaral
- New Jersey26 pag-aaral
- New Mexico3 pag-aaral
- New York40 pag-aaral
- North Carolina26 pag-aaral
- North Dakota4 pag-aaral
- Ohio36 pag-aaral
- Oklahoma12 pag-aaral
- Oregon14 pag-aaral
- Pennsylvania27 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina16 pag-aaral
- South Dakota4 pag-aaral
- Tennessee34 pag-aaral
- Texas51 pag-aaral
- Utah14 pag-aaral
- Vermont3 pag-aaral
- Virginia24 pag-aaral
- Washington25 pag-aaral
- West Virginia5 pag-aaral
- Wisconsin17 pag-aaral
- Wyoming3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03866382DK222 Study at Hopkins
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07140315Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07061964A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06833073Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07206225En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04235764A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06770582A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06172478DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07419295Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Nagre-recruitPhase 1/2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06814496A Study of Surgical Techniques During Cystectomy
Nagre-recruitPhase 3
Edad 21 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06703476A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380Prehabilitation in High-risk Oncologic Surgery
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07638410Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06529822Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06733363Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07667335Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06394570A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217171ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07566156A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07222488Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.